Roxgold Reports Financial Results For Second Quarter 2014
Harwood Feffer LLP Announces Investigation of Intermune, Inc.
Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a component of Roche's immunotherapy assay
Roche and InterMune Reach Definitive Merger Agreement
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of InterMune, Inc. Stockholders
Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis
Genentech Submits Supplemental Biologics License Application to FDA for Lucentis Indication in Diabetic Retinopathy
These quality funds with smaller asset bases have portfolios built around solid companies.
Large drugmakers are out of favor, but some good funds are banking on a rebound.